Myriad Genetics Inc (MYGN)
13.72
+0.06
(+0.48%)
USD |
NASDAQ |
Dec 24, 12:50
Myriad Genetics Total Assets (Quarterly): 1.081B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Haemonetics Corp | 2.525B |
| Boston Scientific Corp | 38.08B |
| Globus Medical Inc | 5.086B |
| ResMed Inc | 7.222B |
| Perspective Therapeutics Inc | 391.15M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 349.60M |
| Shareholders Equity (Quarterly) | 731.70M |
| Debt to Equity Ratio | 0.0533 |
| Current Ratio | 1.900 |
| Net Debt Paydown Yield | -0.00% |